Literature DB >> 25752590

The long-term development of non-motor problems after STN-DBS.

B Lilleeng1, M Gjerstad1, R Baardsen1, I Dalen1, J P Larsen1.   

Abstract

OBJECTIVES: Stimulation of the subthalamic nucleus (STN-DBS) is an established treatment with long-term beneficial effects on motor symptoms in patients with Parkinson's disease (PD). The long-term development of non-motor problems after STN-DBS is not fully understood. In this study, we have studied how non-motor problems develop in patients with and without STN-DBS.
MATERIALS AND METHODS: We collected data from a prospectively followed cohort of patients that had been operated with STN-DBS 6-9 years before final examination and compared our findings to the longitudinal development of non-motor problems in a non-operated, comparable reference population.
RESULTS: In general, the non-motor problems of advanced PD seem to develop independently of treatment with STN-DBS. We found that depressions do not worsen after STN-DBS, and the Montgomery and Aasberg Depression Rating Scale score in operated patients was substantially reduced from pre-operatively to post-operatively. Further, fatigue may represent an important unrecognized side effect of long-term stimulation, as fatigue was found to increase rapidly in operated patients already a year after surgery and continued to increase trough the 6- to 9-year follow-up.
CONCLUSIONS: The non-motor problems of advanced PD seem to develop independently of treatment with STN-DBS. This may influence the strategy for choice of when to perform this therapy for eligible patients.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulator; dementia; depression; fatigue; movement disorders; non-motor problems; sleep disorders

Mesh:

Year:  2015        PMID: 25752590     DOI: 10.1111/ane.12391

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Analyzing 7000 texts on deep brain stimulation: what do they tell us?

Authors:  Christian Ineichen; Markus Christen
Journal:  Front Integr Neurosci       Date:  2015-10-26

2.  Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Panagiotis Bargiotas; Lukas Eugster; Michael Oberholzer; Ines Debove; M Lenard Lachenmayer; Johannes Mathis; Claudio Pollo; W M Michael Schüpbach; Claudio L Bassetti
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

Review 3.  The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Authors:  Giuseppe Loddo; Giovanna Calandra-Buonaura; Luisa Sambati; Giulia Giannini; Annagrazia Cecere; Pietro Cortelli; Federica Provini
Journal:  Front Neurol       Date:  2017-02-16       Impact factor: 4.003

Review 4.  Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis.

Authors:  Thomas J C Zoon; Geeske van Rooijen; Georgina M F C Balm; Isidoor O Bergfeld; Joost G Daams; Paul Krack; Damiaan A J P Denys; Rob M A de Bie
Journal:  Mov Disord       Date:  2020-12-16       Impact factor: 10.338

5.  Subthalamic Nucleus Stimulation in Parkinson's Disease: 5-Year Extension Study of a Randomized Trial.

Authors:  Silje Bjerknes; Mathias Toft; Reidun Brandt; Trine Waage Rygvold; Ane Konglund; Espen Dietrichs; Stein Andersson; Inger Marie Skogseid
Journal:  Mov Disord Clin Pract       Date:  2021-10-18

6.  Managing Intractable Symptoms of Parkinson's Disease: A Nonsurgical Approach Employing Infralow Frequency Neuromodulation.

Authors:  Stella B Legarda; P Andreas Michas-Martin; Dana McDermott
Journal:  Front Hum Neurosci       Date:  2022-07-08       Impact factor: 3.473

Review 7.  How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?

Authors:  Philipp Mahlknecht; Thomas Foltynie; Patricia Limousin; Werner Poewe
Journal:  Mov Disord       Date:  2022-05-12       Impact factor: 9.698

Review 8.  Effects of Deep Brain Stimulation on Sleep-Wake Disturbances in Patients with Parkinson's Disease: A Narrative Review.

Authors:  Yu Jin Jung; Han-Joon Kim; Sun Ha Paek; Beomseok Jeon
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.